Cheng Jie-Kun, Sun Xiao-Hui, Gao Li-Ping, Li Le
College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2016 May 8;32(5):414-418. doi: 10.13459/j.cnki.cjap.2016.05.008.
To investigate the effects and mechanisms of fasudil (Fas) on cardiac hypertrophy (CH) induced by isoprenaline(Iso) in rats.
Except for the normal control group, the rest three groups rats were injected subcutaneously with Iso(5mg/kg) for setting up CH model. SD rats were randomly divided into four groups:Normal control group, Iso model group, Fas with low-dose group (5 mg/kg, i.p) and Fas with high-dose group (20 mg/kg, i.p). Animals were treated with Fas for 8 weeks. After the treatment, the following index were detected:heart rate (HR), left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LVEDP), left ventricular systolic maximum rate (+dp/dt) and left ventricular diastolic maximum rate (-dp/dt). The body weight(BW) and heart weight (HW) were weighed and heart weight index (HWI) was calculateed. Myocardial tissue specimens, HE and Masson staining were performed for observing the histopathological changes. The protein expression of extracellular signal-regulated kinase 1/2 (ERK1/2) in myocardial tissue was determined by using immunohistochemical methods. The expression of ERK1/2 mRNA in the myocardial tissue was detected by using semi-quantitative RT-PCR method.
Compared with normal control group, HR and LVEDP wereincreased significantly, while LVSP and ±dp/dtmax were decreased significantly; HWI was increased significantly in CH group; The myocardial cell volume and the cell gap were increased,cells arranged disorder, and severe myocardial interstitial fibrosis was presented in CH group. The expression of ERK1/2 mRNA was significantly increased. After Fas treatment, the systolic and diastolic functions of heart were improved, cell volume was reduced, cell gap became small, cells arranged in neat rows, and the fibrosis was significantly reduced. The expressions of RhoA, ERK1/2 mRNA were significantly reduced. The damages of myocardial tissue were improved in different degrees.
ERK1/2 signaling pathway is involved in Iso induced CH. Fas protects against the CH of rats induced by Iso, which mechanisms may be related with blocking ERK1/2 signaling pathway.
探讨法舒地尔(Fas)对异丙肾上腺素(Iso)诱导的大鼠心肌肥厚(CH)的影响及其机制。
除正常对照组外,其余三组大鼠皮下注射异丙肾上腺素(5mg/kg)建立心肌肥厚模型。将SD大鼠随机分为四组:正常对照组、Iso模型组、低剂量Fas组(5mg/kg,腹腔注射)和高剂量Fas组(20mg/kg,腹腔注射)。动物接受Fas治疗8周。治疗后,检测以下指标:心率(HR)、左心室收缩压(LVSP)、左心室舒张末期压力(LVEDP)、左心室收缩最大速率(+dp/dt)和左心室舒张最大速率(-dp/dt)。称量体重(BW)和心脏重量(HW)并计算心脏重量指数(HWI)。进行心肌组织标本的HE和Masson染色以观察组织病理学变化。采用免疫组织化学方法测定心肌组织中细胞外信号调节激酶1/2(ERK1/2)的蛋白表达。采用半定量RT-PCR法检测心肌组织中ERK1/2 mRNA的表达。
与正常对照组相比,CH组HR和LVEDP显著升高,而LVSP和±dp/dtmax显著降低;HWI显著升高;心肌细胞体积增大,细胞间隙增宽,细胞排列紊乱,出现严重的心肌间质纤维化。ERK1/2 mRNA表达显著增加。Fas治疗后,心脏的收缩和舒张功能得到改善,细胞体积减小,细胞间隙变小,细胞排列整齐,纤维化显著减轻。RhoA、ERK1/2 mRNA的表达显著降低。心肌组织损伤得到不同程度的改善。
ERK1/2信号通路参与Iso诱导的CH。Fas可保护大鼠免受Iso诱导的CH,其机制可能与阻断ERK1/2信号通路有关。